Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLLT with Immunosuppressants for Dry Eye Disease
NCT07239128Phase 1Completed
- Sponsor
- University of Seville
- Start
- May 2024
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 1, randomised trial (4 arms), sponsored by University of Seville. Primary endpoint: Ocular Surface Disease Index at 12 months. Started May 2024; status: completed.
Beyond the preview
Go deeper on NCT07239128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07239128.